Pay in 4 interest-free payments of $6.83 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
10.1016/j.ijantimicag.2020.106191 96 WeichmannF.RohdewaldP
Archived from the original on November 14, 2019
Multi-Pronged Health Benefits: GLP-1 Agonist enhances cholesterol, blood pressure, inflammation, and other key markers for obesity-related conditions
In this regard, the translational relevance of this preclinical study was demonstrated in patients with obesity by correlation of: (1) circulating FGF21 levels 4 weeks after mRYGB with the initial fat mass and one-year body weight reduction, (2) circulating FFAs with 4 week-body weight loss in mRYGB patients and (3) circulating adiponectin and OXM with weight loss
US$ 27.19
US$ 26.17
US$ 28.22
US$ 20.59
US$ 26.18
US$ 27.68
